Public Employees Retirement Association of Colorado Has $21.76 Million Position in West Pharmaceutical Services, Inc. (WST)

Public Employees Retirement Association of Colorado raised its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 10.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 230,195 shares of the medical instruments supplier’s stock after buying an additional 20,927 shares during the period. Public Employees Retirement Association of Colorado owned about 0.31% of West Pharmaceutical Services worth $21,758,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of WST. Burt Wealth Advisors boosted its stake in shares of West Pharmaceutical Services by 38,540.0% in the first quarter. Burt Wealth Advisors now owns 1,932 shares of the medical instruments supplier’s stock valued at $158,000 after buying an additional 1,927 shares in the last quarter. Harfst & Associates Inc. bought a new stake in shares of West Pharmaceutical Services during the first quarter valued at $186,000. Tyers Asset Management LLC boosted its stake in shares of West Pharmaceutical Services by 17.6% in the first quarter. Tyers Asset Management LLC now owns 2,464 shares of the medical instruments supplier’s stock valued at $201,000 after buying an additional 368 shares in the last quarter. Cutler Group LP boosted its stake in shares of West Pharmaceutical Services by 482.2% in the second quarter. Cutler Group LP now owns 2,550 shares of the medical instruments supplier’s stock valued at $241,000 after buying an additional 2,112 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. raised its position in West Pharmaceutical Services by 1.6% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock worth $210,000 after buying an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 90.51% of the company’s stock.

West Pharmaceutical Services, Inc. (WST) opened at 85.15 on Friday. West Pharmaceutical Services, Inc. has a 1-year low of $70.17 and a 1-year high of $99.91. The stock has a 50 day moving average price of $90.44 and a 200-day moving average price of $88.85. The stock has a market capitalization of $6.30 billion, a P/E ratio of 36.55 and a beta of 1.10.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings results on Thursday, July 27th. The medical instruments supplier reported $0.66 EPS for the quarter, topping the consensus estimate of $0.65 by $0.01. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. The firm had revenue of $397.60 million during the quarter, compared to analyst estimates of $406 million. During the same quarter in the prior year, the business posted $0.59 earnings per share. West Pharmaceutical Services’s revenue for the quarter was up 2.5% compared to the same quarter last year. Equities research analysts expect that West Pharmaceutical Services, Inc. will post $2.69 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 1st. Investors of record on Wednesday, October 18th will be given a dividend of $0.14 per share. This is a positive change from West Pharmaceutical Services’s previous quarterly dividend of $0.13. The ex-dividend date of this dividend is Tuesday, October 17th. This represents a $0.56 annualized dividend and a yield of 0.66%. West Pharmaceutical Services’s dividend payout ratio is 22.22%.

TRADEMARK VIOLATION NOTICE: This article was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.com-unik.info/2017/08/19/public-employees-retirement-association-of-colorado-has-21-76-million-stake-in-west-pharmaceutical-services-inc-wst-updated-updated.html.

A number of research analysts have commented on the company. Zacks Investment Research raised West Pharmaceutical Services from a “hold” rating to a “strong-buy” rating and set a $114.00 target price for the company in a research report on Friday, June 9th. BidaskClub downgraded West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research note on Wednesday, July 5th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $90.18.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

What are top analysts saying about West Pharmaceutical Services Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for West Pharmaceutical Services Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit